Triazolo-pyridazine derivatives as ligands for gaba receptors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/50 (2006.01) C07D 237/00 (2006.01) C07D 249/00 (2006.01)

Patent

CA 2315763

A class of substituted 1,2,4-triazolo[4,3-b]pyridazine derivatives, possessing a fluoro-substituted phenyl ring at the 3-position and a heteroaryl-methoxy moiety at the 6-position, are selective ligands for GABA A receptors, in particular having high affinity for the .alpha.2 and/or .alpha.3 subunit thereof, and are accordingly of benefit in the treatment and/or prevention of disorders of the central nervous system, including anxiety and convulsions.

L'invention porte sur une classe de dérivés substitués de la 1,2,4-triazolo[4,3-b] pyridazine présentant un cycle phényle à substitution fluoro en position 3-, et un fragment hétéroaryle-méthoxy en position 6-. Ces dérivés, ligands sélectifs des récepteurs du GABAA, ont une forte affinité pour ses sous-unités alpha 2 et/ou alpha 3, et exercent de ce fait une action bénéfique dans le traitement ou la prévention de troubles du SNC, dont l'anxiété et les convulsions.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Triazolo-pyridazine derivatives as ligands for gaba receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Triazolo-pyridazine derivatives as ligands for gaba receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazolo-pyridazine derivatives as ligands for gaba receptors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1994630

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.